Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
BOULDER, Colo.--(BUSINESS WIRE)--May 6, 2019--Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the Bank of America Merrill Lynch Healthcare Conference 2019 on Tuesday, May 14, 2019 at 2:20 PM Pacific Time. The conference will be held at the Encore Hotel in Las Vegas, Nevada.
A live webcast of the presentation can be accessed through the investor relations section of the Company’s website at www.clovisoncology.com. Following the live presentation, a replay of the webcast will be available on the Company’s website for 30 days.
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190506005004/en/
CONTACT: Anna Sussman
KEYWORD: UNITED STATES NORTH AMERICA COLORADO
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS HOSPITALS ONCOLOGY PHARMACEUTICAL MEDICAL SUPPLIES
SOURCE: Clovis Oncology, Inc.
Copyright Business Wire 2019.
PUB: 05/06/2019 08:00 AM/DISC: 05/06/2019 08:01 AM